GlassScriptPhysician profile
Gregory S Nishimura
NPI 1881744795
$12,187.75
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $44.82 · 2021: $1,198 · 2022: $9,820 · 2023: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,257.72 | 2019-2023 | |
| Medtronic, INC. | $976.77 | 2021-2023 | Signia |
| Apollo Endosurgery US INC | $888.55 | 2022 | |
| Covidien LP | $494.56 | 2019-2020 | |
| Intra-Sana Laboratories | $354.69 | 2021 | |
| Teleflex LLC | $270.61 | 2022-2023 | Titan Sgs Standard Gastric Stapler |
| Boston Scientific Corporation | $187.50 | 2021 | |
| Standard Bariatrics, INC. | $133.19 | 2022 | |
| Redhill Biopharma INC. | $118.39 | 2021 | |
| Avanos Medical | $115.28 | 2019 | |
| Triad Life Sciences INC. | $100.00 | 2022 | |
| Endogastric Solutions, INC | $86.20 | 2019 | |
| W. L. Gore & Associates, INC. | $86.09 | 2021 | |
| Baxter Healthcare | $42.82 | 2019 | |
| Kci USA, INC. | $31.93 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $26.96 | 2019-2023 | Caldolor |
| Olympus America INC. | $16.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Nishimura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.